-+ 0.00%
-+ 0.00%
-+ 0.00%

Morphosis Capital completes sale of Medima stake to Simago

PUBT·11/19/2026 11:29:35
Listen to the news
Morphosis Capital completes sale of Medima stake to Simago
  • Simago acquired a majority stake in Medima, completing Morphosis Capital Fund I's exit.
  • The sale delivered a 4.3x multiple on invested capital and a 31% internal rate of return for the fund.
  • Co-founder Vlad Ardeleanu retained his entire stake and will continue as CEO alongside the current management team.
  • Medima operates 34 diagnostic-imaging clinics across 30 Romanian cities.
  • The acquisition marks Ardian-backed Simago's first investment in Central and Eastern Europe.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Morphosis Capital SRL published the original content used to generate this news brief on November 19, 2026, and is solely responsible for the information contained therein.